1. Home
  2. Companies
  3. RCE
  4. Announcements

Recce Pharmaceuticals (ASX:RCE)

ASX announcement history & article coverage

21
Total announcements
(in last 3 months)
6
With article
15
No article
Article coverage
29%
Transparent by design. Announcments by Recce Pharmaceuticals (ASX:RCE) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

6 July 2026 · 09:06 am AEST ASX Filing
Share Purchase Plan - Letter and Offer Booklet
Letter to ShareholdersSecurity Purchase Plan
3 July 2026 · 02:31 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
3 July 2026 · 02:25 pm AEST ASX Filing
Application for quotation of securities - RCE
Appendix 2A
2 July 2026 · 04:26 pm AEST ASX Filing
Notification of cessation of securities - RCE
Appendix 3H (Notification of cessation of securities)
1 July 2026 · 11:30 am AEST ASX Filing
Cleansing Notice
Cleansing Notice
1 July 2026 · 11:24 am AEST ASX Filing
Application for quotation of securities - RCE
Appendix 2A
1 July 2026 · 11:10 am AEST ASX Filing
Application for quotation of securities - RCE
Appendix 2A
1 July 2026 · 11:04 am AEST ASX Filing
Application for quotation of securities - RCE
Appendix 2A
1 July 2026 · 09:07 am AEST ⚡ Price SensitiveMaterial ASX Filing
AUD $3.7M Income Tax Refund Received
Recce Pharmaceuticals receives AUD 3.7 million tax refund, boosts cash position ahead of Phase 3 trials
Progress ReportCompany Administration - Other
70
Recce Pharmaceuticals Boosts Cash with A$3.7 Million Tax Refund Ahead of Phase 3 Trials Healthcare Wrap - Week 27 (29 June -> 3 July) 2026 Wrap

26 June 2026 · 06:00 pm AEST ASX Filing
Proposed issue of securities - RCE
Appendix 3B (Proposed issue of securities)
26 June 2026 · 10:35 am AEST ASX Filing
RCE Investor Presentation
Company Presentation
26 June 2026 · 10:19 am AEST ASX Filing
Proposed issue of securities - RCE
Appendix 3B (Proposed issue of securities)
26 June 2026 · 10:03 am AEST ⚡ Price SensitiveMaterial ASX Filing
Placement & SPP to raise $8 million
Recce Pharmaceuticals raises A$4 million via placement and launches Share Purchase Plan
PlacementTrading Halt Lifted
85
Recce Pharmaceuticals Raises A$4 Million to Fuel Licensing and Clinical Trials Healthcare Wrap - Week 26 (22 June -> 26 June) 2026 Wrap Market Wrap - Week 26 (22 June -> 26 June) 2026 Wrap
24 June 2026 · 10:08 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
Trading Halt
24 June 2026 · 09:54 am AEST ⚡ Price SensitiveMaterial ASX Filing
Pause in Trading
Recce Pharmaceuticals requests trading halt pending further announcement
Notice Pending
40
22 June 2026 · 10:03 am AEST ⚡ Price SensitiveMaterial ASX Filing
HREC Approval Accelerates Global Phase 3 DFI Strategy
Recce Pharmaceuticals advances pivotal Phase 3 trial for diabetic foot infections with expanded patient eligibility
Progress Report
85
Recce Pharmaceuticals Expands Phase 3 Trial for Diabetic Foot Infections with Broader Patient Scope Healthcare Wrap - Week 26 (22 June -> 26 June) 2026 Wrap

27 May 2026 · 01:49 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Addendum to Recce Signs Middle East Licensing Term Sheet
Recce Pharmaceuticals clarifies Middle East licensing term sheet details and confirms counterparty's financial strength
Progress Report
60
27 May 2026 · 09:48 am AEST ⚡ Price SensitiveMaterial ASX Filing
Recce Signs Middle East Licensing Term Sheet
Recce Pharmaceuticals Signs 10-Year Exclusive Licensing Term Sheet for R327 Gel in MENA Region
Progress Report
85
Recce Pharmaceuticals Secures 10-Year Licensing Deal for R327 Gel in MENA Market Wrap - Week 22 (25 May -> 29 May) 2026 Wrap Healthcare Wrap - Week 22 (25 May -> 29 May) 2026 Wrap

30 Apr 2026 · 05:03 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
Recce Pharmaceuticals advances clinical trials, secures U.S. Army collaboration and Brazil patent; receives $5.3M AUD R&D rebate
Commitments Test Entity - Third Quarter Activity ReportCommitments Test Entity - Third Quarter Cashflow Report
85
Recce Pharmaceuticals Secures $5.3M R&D Rebate, Advances U.S. Army Burn Wound Collaboration Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap
21 Apr 2026 · 10:52 am AEST Material ASX Filing
Positive Regulatory Inspection Outcome for Phase 3 Trial
Recce Pharmaceuticals clears Indonesian regulatory inspection for Phase 3 diabetic foot infection trial
Progress Report
75
Recce Pharmaceuticals Passes Key Indonesian Inspection for Phase 3 Diabetic Foot Infection Trial Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026 Wrap
15 Apr 2026 · 05:28 pm AEST ASX Filing
Notification of cessation of securities - RCE
Appendix 3H (Notification of cessation of securities)